(S)-2-[(甲氧羰基)氨基]-1,2,3,4-四氢萘-1-酮 | 86411-23-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 四氢化萘
• 中文名称: (S)-2-[(甲氧羰基)氨基]-1,2,3,4-四氢萘-1-酮
• 英文名称: (S)-2-<(Methoxycarbonyl)amino>-1,2,3,4-tetrahydronaphthalen-1-one
• 英文别名: methyl (2S)-(1,2,3,4-tetrahydro-1-oxo-2-naphthalenyl)carbamate；(S)-2-[(Methoxycarbonyl)amino]-1,2,3,4-tetrahydronaphthalen-1-one；methyl N-[(2S)-1-oxo-3,4-dihydro-2H-naphthalen-2-yl]carbamate
• CAS: 86411-23-6
• 化学式: C₁₂H₁₃NO₃
• 分子量: 219.24
• InChiKey: OVFZYKQHMPFGQT-JTQLQIEISA-N

物化性质

• 熔点：
  125-127 °C
• 沸点：
  391.1±32.0 °C(Predicted)
• 密度：
  1.23±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  55.4
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (S)-2-[(甲氧羰基)氨基]-1,2,3,4-四氢萘-1-酮 在 potassium fluoride 、 lithium aluminium tetrahydride 、 正丁基锂 作用下， 以 四氢呋喃 、 正己烷 、 二氯甲烷 、 乙腈 为溶剂， 反应 137.5h， 生成 trans-(-)-(6aS,13bR)-11-chloro-6,6a,7,8,9,13b-hexahydro-7-methyl-12-methoxy-5H-benzonaphth<2,1-b>azepine
  参考文献：
  名称：

  Novel Stereoselective Syntheses of the Fused Benzazepine Dopamine D₁ Antagonist (6aS,13bR)-11-Chloro-6,6a,7,8,9,13b-hexahydro-7-methyl-5H- benzo[d]naphth[2,1-b]azepin-12-ol (Sch 39166):  1. Aziridinium Salt Based Syntheses

  摘要：

  Several novel enantioselective syntheses of the dopamine D-1 antagonist (6aS,13bR)-11-chloro-6,6a,7,8,9,13b-hexahydro-7- methyl-5H-benzo[d]naphth[2,1-b]azepin-12-ol (2) are described in which the key intermediate was 1-(2,2 dimethoxyethyl)-1-methyl-1a,2,3,7b-tetrahydro-1H-naphth[1,2-b] aziridinium salt (20), The latter species was prepared either from 1-(2,2-dimethoxyethyl)-1a,2,3,7b-tetrahydro-]H-naphth[1,2-b]- azirine (18) by methylation or from the tertiary amino alcohols 1-[(2,2-dimethoxyethyl)methylamino]-1,2,3,4-tetrahydro-2 -naphthalenol (23) or 2-[(2,2-dimethoxyethyl)methylamino]-1,2,3,4-tetrahydro -1-naphthalenol (24) by tosylation and in situ ring closure. Regioselective trapping of 20 with Grignard reagent (4-chloro-3-methoxyphenyl)magnesium bromide (10) then afforded the transamine 1-(4-chloro-3-methoxyphenyl)-N-(2,2-dimethoxyethyl)-1,2,3,4 -tetrahydro-N-methyl-2-naphth-alenamine (22), which was cyclized to give 11-chloro-6,6a,7,8,9,13b-hexahydro-7-methyl-12-methoxy-5H-benzo [d]- naphth[2,1-b]azepine (9), a known precursor of 2, Several enantioselective syntheses, including a Jacobsen epoxidation route, a de novo synthesis from L-homophenylalanine, and a classical salt resolution sequence, were developed for the preparation of the key intermediates in chiral form.

  DOI：

  10.1021/op970121s
• 作为产物：
  描述：

  (S)-2-<(Methoxycarbonyl)amino>-4-phenylbutanoic Acid 在 三氯化铝 、 五氯化磷 作用下， 生成 (S)-2-[(甲氧羰基)氨基]-1,2,3,4-四氢萘-1-酮
  参考文献：
  名称：

  1,4-Oxazines via intramolecular ring closure of .beta.-hydroxydiazoacetamides: phenylalanine to tetrahydroindeno[1,2-b]-1,4-oxazin-3(2H)-ones

  摘要：

  DOI：

  10.1021/jo00164a009

文献信息

• 1,4-Oxazines via intramolecular ring closure of .beta.-hydroxydiazoacetamides: phenylalanine to tetrahydroindeno[1,2-b]-1,4-oxazin-3(2H)-ones
  作者：D. E. McClure、P. K. Lumma、B. H. Arison、J. H. Jones、J. J. Baldwin

  DOI：10.1021/jo00164a009

  日期：1983.8
• Draper, Richard W.; Hou, Donald, Organic Process Research and Development, 1998, vol. 2, # 3, p. 186 - 193
  作者：Draper, Richard W.、Hou, Donald

  DOI：——

  日期：——
• MCCLURE, D. E.;LUMMA, P. K.;ARISON, B. H.;JONES, J. H.;BALDWIN, J. J., J. ORG. CHEM., 1983, 48, N 16, 2675-2679
  作者：MCCLURE, D. E.、LUMMA, P. K.、ARISON, B. H.、JONES, J. H.、BALDWIN, J. J.

  DOI：——

  日期：——
• Novel Stereoselective Syntheses of the Fused Benzazepine Dopamine D₁ Antagonist (6a<i>S</i>,13b<i>R</i>)-11-Chloro-6,6a,7,8,9,13b-hexahydro-7-methyl-5<i>H</i>- benzo[<i>d</i>]naphth[2,1-<i>b</i>]azepin-12-ol (Sch 39166):  1. Aziridinium Salt Based Syntheses
  作者：Richard W. Draper、Donald Hou、Radha Iyer、Gary M. Lee、Jimmy T. Liang、Janet L. Mas、Wanda Tormos、Eugene J. Vater、Frank Günter、Ingrid Mergelsberg、Dominik Scherer

  DOI：10.1021/op970121s

  日期：1998.5.1

  Several novel enantioselective syntheses of the dopamine D-1 antagonist (6aS,13bR)-11-chloro-6,6a,7,8,9,13b-hexahydro-7- methyl-5H-benzo[d]naphth[2,1-b]azepin-12-ol (2) are described in which the key intermediate was 1-(2,2 dimethoxyethyl)-1-methyl-1a,2,3,7b-tetrahydro-1H-naphth[1,2-b] aziridinium salt (20), The latter species was prepared either from 1-(2,2-dimethoxyethyl)-1a,2,3,7b-tetrahydro-]H-naphth[1,2-b]- azirine (18) by methylation or from the tertiary amino alcohols 1-[(2,2-dimethoxyethyl)methylamino]-1,2,3,4-tetrahydro-2 -naphthalenol (23) or 2-[(2,2-dimethoxyethyl)methylamino]-1,2,3,4-tetrahydro -1-naphthalenol (24) by tosylation and in situ ring closure. Regioselective trapping of 20 with Grignard reagent (4-chloro-3-methoxyphenyl)magnesium bromide (10) then afforded the transamine 1-(4-chloro-3-methoxyphenyl)-N-(2,2-dimethoxyethyl)-1,2,3,4 -tetrahydro-N-methyl-2-naphth-alenamine (22), which was cyclized to give 11-chloro-6,6a,7,8,9,13b-hexahydro-7-methyl-12-methoxy-5H-benzo [d]- naphth[2,1-b]azepine (9), a known precursor of 2, Several enantioselective syntheses, including a Jacobsen epoxidation route, a de novo synthesis from L-homophenylalanine, and a classical salt resolution sequence, were developed for the preparation of the key intermediates in chiral form.
• Org. Process Res. Dev. 1998, 2, 186-193
  作者：

  DOI：——

  日期：——